Pharmaceutisch Weekblad

, Volume 10, Issue 4, pp 158–169 | Cite as

Clinical education for hospital pharmacists in the Netherlands and the United States of America: Some observations

  • Abraham G. Hartzema
  • Lyda Blom
Quality Control in Hospital Pharmacy


Three parameters for the quality of clinical education for hospital pharmacists are postulated: the number of pharmacists who can serve as preceptors, the depth and scope of clinical pharmacy services, and the structure of the training. Dutch hospital pharmacies exhibit consistently lower pharmacist staffing ratios than their American counterparts. For the scope of services provided in Dutch (as compared to American) hospitals, the emphasis is on pharmacokinetic consultation and handling of radiopharmaceuticals, services which require less patient involvement and are consequently less labour intensive than services, such as patient profile and drug interaction monitoring services, which are more prevalent in American hospital pharmacies. 17% Of Dutch respondents were not exposed to patient profile monitoring during their training, 16% were not exposed to drug interactions monitoring, 9.8% were not exposed to pharmacokinetic services and 8.9% were not exposed to drug information services, although these services are provided at the current worksite. Dutch hospital pharmacists are often solo practitioners maintaining a high standard of practice by focusing on core tasks and activities.


Cost and cost analysis Education, pharmacy Pharmacists, hospital Quality control 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Schobben AFAM. Pharmacokinetic services by the hospital pharmacist. Ziekenhuisfarmacie 1987;3:97–8.Google Scholar
  2. 2.
    Clinical Practice Affairs Committee of the American College of Clinical Pharmacy, 1985–1986. Minimum practice standards for clinical pharmacy specialists with interpretation for organized health care settings. Drug Intell Clin Pharm 1987;21:645–52.Google Scholar
  3. 3.
    Kutsch Lojenga JC. Hospital pharmacy in the Netherlands: a letter from Holland. Pharm Weekbl 1987;122:756–9.Google Scholar
  4. 4.
    Berman A. American hospital pharmacy: a bicentennial perspective. Am J Hosp Pharm 1976;33:129–33.PubMedGoogle Scholar
  5. 5.
    Parker PF. Reflections on clinical pharmacy's first 20 years. Am J Hosp Pharm 1985;42:1293–7.PubMedGoogle Scholar
  6. 6.
    Anonymous. Memorandum voor de apotheker deel 11, Ledenen Adressenlijst [Memorandum for the pharmacist part II. Membership and addresslist]. 's-Gravenhage: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, 1987:361–9.Google Scholar
  7. 7.
    Anonymous. Lilly Hospital Pharmacy Survey. Indianapolis: Eli Lilly and Company, 1987.Google Scholar
  8. 8.
    Anonymous. KNMP-Registratieregeling voor ziekenhuisapothekers en voor openbare apothekers [Registration scheme for hospital pharmacists and for community pharmacists]. 's-Gravenhage: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, 1986.Google Scholar
  9. 9.
    Anonymous. Taken en functies van de ziekenhuisfarmacie [Tasks and duties of hospital pharmacy]. Dordrecht: Nederlandse Vereniging van Ziekenhuisapothekers, 1980.Google Scholar
  10. 10.
    Anonymous. Projet de Formation du Pharmacien specialiste en pharmacie hospitalière. Paris, June 1987.Google Scholar
  11. 11.
    Cox AB. Om de kwaliteit van de beroepsuitoefening. [For the quality of occupational performance] Pharm Weekbl 1985;120:905–9.Google Scholar
  12. 12.
    Gray DR, Ho MI, Cavale KL, Maki JK, Flader JA, Chretien SD. Workload measurement of a clinical pharmacy residency program. Am J Hosp Pharm 1987;44:557–61.PubMedGoogle Scholar
  13. 13.
    Juul Christensen EK. The Academic Hospital Pharmacy in Groningen. Pharm Int 1981;3:21–2.Google Scholar
  14. 14.
    Anonymous. Legal Update: Seminar examines Gramm-Rudman, Medicare, and drug diversion. Hosp Pharm Cost Containment 1987;5(1).Google Scholar
  15. 15.
    Barzansky B, Beckman CRR. Evaluation of a clinical program. Eval Health Prof 1985;8:2, 193–208.PubMedGoogle Scholar
  16. 16.
    Stolar MH. National survey of hospital pharmaceutical services — 1985. Am J Hosp Pharm 1985;42:2667–78.PubMedGoogle Scholar
  17. 17.
    Graham JR. Systematic evaluation of clinical competence. J Med Educ 1971;46:625–9.PubMedGoogle Scholar
  18. 18.
    McGaghie WC. The evaluation of competence, validity issues in the health professions. Eval Health Prof 1980;3:289–321.PubMedGoogle Scholar
  19. 19.
    Bureau of Health Professions, Health Resources and Services Administration. Issues affecting the financing of clinical education. Washington: Department of Health and Human Services, 1984.Google Scholar
  20. 20.
    Leiken AM, Stern E, Baines RE. The effect of clinical education programs on hospital production. Inquiry 1983;20:88–92.PubMedGoogle Scholar
  21. 21.
    Scully RM, Shepard KF. Clinical teaching in physical therapy education. An ethnographic study. Phys Ther 1983;63:349–58.PubMedGoogle Scholar
  22. 22.
    Anonymous. APhA national survey: willingness of consumers to pay for pharmacists' clinical services. Am Pharm 1983;23:58–64.Google Scholar
  23. 23.
    Penna RP, Knapp DA. Impact of federal reimbursement changes on clinical pharmacy education and training. Am J Pharm Educ 1986;50:296–300.PubMedGoogle Scholar
  24. 24.
    Anonymous. Directions for clinical practice pharmacy. Proceedings of an invitational conference conducted by the ASHP Research and Education Foundation and the American Society of Hospital Pharmacists. Am J Hosp Pharm 1985;42:1287–341.Google Scholar
  25. 25.
    Anonymous. Advancing clinical pharmacy services, focusing on quality and cost-effectiveness. Deerfield: Travenol Laboratories, 1987.Google Scholar
  26. 26.
    Britton HL, Schwinghammer TL, Romano M. Cost containment through restriction of cephalosporins. Am J Hosp Pharm 1981;38:1897–900.PubMedGoogle Scholar
  27. 27.
    Fink A, Kosecoff J, Oppenheimer PR, Smith WE, Brodie DC. Assessing whether a clinical pharmacy program is meeting its goals. Am J Hosp Pharm 1982;39:806–10.PubMedGoogle Scholar
  28. 28.
    McGhan WF, Rowland CR, Bootman JL. Cost-benefit and cost-effectiveness: methodologies for evaluating innovative pharmaceutical services. Am J Hosp Pharm 1978;35:133–44.Google Scholar
  29. 29.
    Abramowitz PW, Nold EG, Hatfield SM. Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs. Am J Hosp Pharm 1982;39:1176–80.PubMedGoogle Scholar
  30. 30.
    Miyagawa CI, Rivera JO. Effect of pharmacist intervention on drug therapy costs in a surgical intensivecare unit. Am J Hosp Pharm 1986;43:3008–13.PubMedGoogle Scholar
  31. 31.
    Smith JE, Sheaffer SL. Marketing clinical pharmacy services. Top Hosp Management 1985;5:53–62.Google Scholar
  32. 32.
    Pierpaoli PG, Anderson RW, Kelly WN, Linggi A, Pelham LD. Strategic planning for clinical services. panel discussion. Am J Hosp Pharm 1986;43:2174–7.PubMedGoogle Scholar
  33. 33.
    Miller WA. Building our image as a clinical profession. Am J Hosp Pharm 1985;42:1323–30.PubMedGoogle Scholar
  34. 34.
    Anonymous. Directions for clinical pharmacy practice in Pennsylvania, April 8–10, 1986, Lancaster. Philadelphia: Pennsylvania Society of Hospital Pharmacists, 1986.Google Scholar
  35. 35.
    Anonymous. Minimum practice standards for clinical pharmacy specialists with interpretation for organized health-care settings. Drug Intell Clin Pharm 1987;21:645–7.Google Scholar
  36. 36.
    Lennarson Greer A. Medical technology and professional dominance theory. Soc Sci Med 1984;18:809–17.CrossRefPubMedGoogle Scholar
  37. 37.
    Freidson E. Professional dominance. Atherton Press, Inc., 1970:27–61.Google Scholar
  38. 38.
    Starr P. The social transformation of American medicine. New York: Basic Books, Inc., Publishers, 1982:3–29.Google Scholar
  39. 39.
    Ritchey FJ, Raney MR. Medical role-task boundary maintenance: physicians' opinions on clinical pharmacy. Med Care 1981;19:90–103.PubMedGoogle Scholar
  40. 40.
    Phillips RC, Lipman AG. Physicians' perceptions of clinical pharmacy service. Hosp Form 1981;16:988–1000.Google Scholar
  41. 41.
    Enright SM. Supply of physicians. Am J Hosp Pharm 1986;43:3042–5.PubMedGoogle Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1988

Authors and Affiliations

  • Abraham G. Hartzema
    • 1
  • Lyda Blom
    • 2
  1. 1.School of PharmacyUniversity of North CarolinaChapel HillUSA
  2. 2.Department of Social PharmacyState University of UtrechtAD Utrechtthe Netherlands

Personalised recommendations